287 related articles for article (PubMed ID: 29880032)
1. Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.
Li Z; Del-Aguila JL; Dube U; Budde J; Martinez R; Black K; Xiao Q; Cairns NJ; ; Dougherty JD; Lee JM; Morris JC; Bateman RJ; Karch CM; Cruchaga C; Harari O
Genome Med; 2018 Jun; 10(1):43. PubMed ID: 29880032
[TBL] [Abstract][Full Text] [Related]
2. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.
Zhou Y; Song WM; Andhey PS; Swain A; Levy T; Miller KR; Poliani PL; Cominelli M; Grover S; Gilfillan S; Cella M; Ulland TK; Zaitsev K; Miyashita A; Ikeuchi T; Sainouchi M; Kakita A; Bennett DA; Schneider JA; Nichols MR; Beausoleil SA; Ulrich JD; Holtzman DM; Artyomov MN; Colonna M
Nat Med; 2020 Jan; 26(1):131-142. PubMed ID: 31932797
[TBL] [Abstract][Full Text] [Related]
3. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
4. Peripheral TREM2 mRNA levels in early and late-onset Alzheimer disease's patients.
Guven G; Bilgic B; Samanci B; Gurvit H; Hanagasi H; Donmez C; Aslan R; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2020 Aug; 47(8):5903-5909. PubMed ID: 32681391
[TBL] [Abstract][Full Text] [Related]
5. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
[TBL] [Abstract][Full Text] [Related]
6. From Common to Rare Variants: The Genetic Component of Alzheimer Disease.
Nicolas G; Charbonnier C; Campion D
Hum Hered; 2016; 81(3):129-141. PubMed ID: 28002825
[TBL] [Abstract][Full Text] [Related]
7. TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.
Del-Aguila JL; Benitez BA; Li Z; Dube U; Mihindukulasuriya KA; Budde JP; Farias FHG; Fernández MV; Ibanez L; Jiang S; Perrin RJ; Cairns NJ; Morris JC; Harari O; Cruchaga C
Mol Neurodegener; 2019 May; 14(1):18. PubMed ID: 31068200
[TBL] [Abstract][Full Text] [Related]
8. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
[TBL] [Abstract][Full Text] [Related]
9. A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.
Del-Aguila JL; Li Z; Dube U; Mihindukulasuriya KA; Budde JP; Fernandez MV; Ibanez L; Bradley J; Wang F; Bergmann K; Davenport R; Morris JC; Holtzman DM; Perrin RJ; Benitez BA; Dougherty J; Cruchaga C; Harari O
Alzheimers Res Ther; 2019 Aug; 11(1):71. PubMed ID: 31399126
[TBL] [Abstract][Full Text] [Related]
10. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
11. APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop.
Murray CE; King A; Troakes C; Hodges A; Lashley T
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):183-186. PubMed ID: 29411406
[No Abstract] [Full Text] [Related]
12. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
[TBL] [Abstract][Full Text] [Related]
13. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
[TBL] [Abstract][Full Text] [Related]
14. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
15. Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of
Han S; Na Y; Koh I; Nho K; Lee Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576031
[No Abstract] [Full Text] [Related]
16. Variant of TREM2 associated with the risk of Alzheimer's disease.
Jonsson T; Stefansson H; Steinberg S; Jonsdottir I; Jonsson PV; Snaedal J; Bjornsson S; Huttenlocher J; Levey AI; Lah JJ; Rujescu D; Hampel H; Giegling I; Andreassen OA; Engedal K; Ulstein I; Djurovic S; Ibrahim-Verbaas C; Hofman A; Ikram MA; van Duijn CM; Thorsteinsdottir U; Kong A; Stefansson K
N Engl J Med; 2013 Jan; 368(2):107-16. PubMed ID: 23150908
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
18. A loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers.
Ayers KL; Mirshahi UL; Wardeh AH; Murray MF; Hao K; Glicksberg BS; Li S; Carey DJ; Chen R
BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):445. PubMed ID: 27358062
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.
Novotny BC; Fernandez MV; Wang C; Budde JP; Bergmann K; Eteleeb AM; Bradley J; Webster C; Ebl C; Norton J; Gentsch J; Dube U; Wang F; Morris JC; Bateman RJ; Perrin RJ; McDade E; Xiong C; Chhatwal J; ; ; ; Goate A; Farlow M; Schofield P; Chui H; Karch CM; Cruchaga C; Benitez BA; Harari O
Alzheimers Dement; 2023 May; 19(5):1785-1799. PubMed ID: 36251323
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]